September 13, 2021 Enzychem Lifesciences Announces Database Lock for Phase 2 Study of EC-18 in Chemoradiation-Induced Oral Mucositis Explore further
September 13, 2021 Enzychem Lifesciences Announces Database Lock for Phase 2 Study of EC-18 in Chemoradiation-Induced Oral Mucositis Explore further
September 9, 2021 U.S. Severe Oral Mucositis Market to Surpass US$ 267.7 Million by 2028, Says Coherent Market Insights (CMI) Explore further
September 9, 2021 Oral Mucositis (OM) Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com Explore further
